La vulvodinia es un problema bastante más frecuente que lo que se puede percibir en las consultas de médicos de familia o ginecólogos.

Se trata de un síndrome de dolor vulvar inexplicable, con frecuencia acompañado de discapacidades físicas, limitación de las actividades diarias, la disfunción sexual y la angustia psicológica. El dolor en la vulva de la paciente por lo general tiene un comienzo agudo y, en la mayoría de los casos, se convierte en un problema crónico que dura meses o años. El dolor es a menudo descrito como ardor o escozor, o una sensación de aspereza o irritación.

La vulvodinia (Terminología ISSVD 2003) puede estar relacionada con un trastorno específico (infeccioso, inflamatorio, neoplásico o neurológico) o tratarse de una vulvodinia esencial. La vulvodinia esencial puede ser generalizada o localizada y aparecer de forma espontánea o provocada.

La evaluación debe incluir una historia detallada y un examen físico, así como cultivos de bacterias y hongos, y biopsia de cualquier área sospechosa.

El tratamiento ha de adecuarse a la identificación del tipo concreto de vulvodinia. Dependiendo del diagnóstico específico, el tratamiento puede incluir el fluconazol, antibioterapia,  citrato de calcio, antidepresivos tricíclicos, corticoides tópicos, terapia física con el biofeedback, la cirugía o láserterapia. Dado que la vulvodinia es a menudo una condición crónica, regular un seguimiento médico y la conjunción de un grupo de apoyo son útiles para la mayoría de las pacientes.

APOYO ICONOGRAFICO A LA EXPOSICIÓN

1. Reed BD, Gorenflo DW, Haefner HK. Generalized vulvar dysesthesia vs. vestibulodynia. Are they distinct diagnoses? J Reprod Med 2003; 48:858-64.

2. Skene AJ. Treatise on the diseases of women, for the use of students and practitioners. New York: Appleton, 1889.

3. Young AW. Burning vulva syndrome: report of the ISSVD task force. J Reprod Med 1984;29:457.

4. Moyal-Barracco M, Lynch PJ. 2003 ISSVD terminology and classification of vulvodynia: a historical perspective. J Reprod Med 2004;49:772-7.

5. Goetsch MF. Vulvar vestibulitis: prevalence and historic features in a general gynecologic practice population. Am J Obstet Gynecol 1991;164(6 pt 1):1609-14.

6. Reed BD, Crawford S, Couper M, Cave C, Haefner HK. Pain at the vulvar vestibule: a web-based survey. J Low Genit Tract Dis 2004;8:48-57.

7. Harlow BL, Stewart EG. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc 2003;58:82-8.

8. Foster DC. Case-control study of vulvar vestibulitis syndrome. J Womens Health 1995;6:677-80.

9. Reed BD, Haefner HK, Cantor L. Vulvar dysesthesia (vulvodynia). A follow-up study. J Reprod Med 2003;48:409-16.

10. Bazin S, Bouchard C, Brisson J, Morin C, Meisels A, Fortier M. Vulvar vestibulitis syndrome: an exploratory case-control study. Obstet Gynecol 1994;83:47-50.

11. Nyirjesy P. Vulvar vestibulitis syndrome: a post-infectious entity? Curr Infect Dis Rep 2000;2:531-5.

12. Lynch PJ. Vulvodynia: a syndrome of unexplained vulvar pain, psychologic disability and sexual dysfunction. J Reprod Med 1986;31:773-80.

13. Stewart DE, Reicher AE, Gerulath AH, Boydell KM. Vulvodynia and psychological distress. Obstet Gynecol 1994;84:587-90.

14. Reed BD, Haefner HK, Punch MR, Roth RS, Gorenflo DW, Gillespie BW. Psychosocial and sexual functioning in women with vulvodynia and chronic pelvic pain. A comparative evaluation. J Reprod Med 2000;45:624-32.

15. Meana M, Binik YM, Khalife S, Cohen DR. Biopsychosocial profile of women with dyspareunia. Obstet Gynecol 1997;90(4 pt 1):583-9.

16. Van Lankveld JJ, Weijenborg PT, ter Kuile MM. Psychologic profiles of and sexual function in women with vulvar vestibulitis and their partners. Obstet Gynecol 1996;88:65-70.

17. Edwards L, Mason M, Phillips M, Norton J, Boyle M. Childhood sexual and physical abuse. Incidence in patients with vulvodynia. J Reprod Med 1997;42:135-9.

18. Reed BD, Advincula AP, Fonde KR, Gorenflo DW, Haefner HK. Sexual activities and attitudes of women with vulvar dysesthesia. Obstet Gynecol 2003;102:325-31.

19. Glazer HI, Jantos M, Hartmann EH, Swencionis C. Electromyographic comparisons of the pelvic floor in women with dysesthetic vulvodynia and asymptomatic women. J Reprod Med 1998;43:959-62.

20. McKay E, Kaufman RH, Doctor U, Berkova Z, Glazer H, Redko V. Treating vulvar vestibulitis with electromyographic biofeedback of pelvic floor musculature. J Reprod Med 2001;46:337-42.

21. Glazer HI. Dysesthetic vulvodynia. Long-term follow-up after treatment with surface electromyography-assisted pelvic floor muscle rehabilitation. J Reprod Med 2000;45:798-802.

22. Pukall CF, Binik YM, Khalife S, Amsel R, Abbott FV. Vestibular tactile and pain thresholds in women with vulvar vestibulitis syndrome. Pain 2002;96:163-75.

23. Giesecke J, Reed BD, Haefner HK, Giesecke T, Clauw DJ, Gracely RH. Quantitative sensory testing in vulvodynia patients and increased peripheral pressure pain sensitivity. Obstet Gynecol 2004;104:126-33.

24. Foster DC, Hasday JD. Elevated tissue levels of interleukin-1 beta and tumor necrosis factor-alpha in vulvar vestibulitis. Obstet Gynecol 1997; 89:291-6.

25. Gerber S, Bongiovanni AM, Ledger WJ, Witkin SS. Defective regulation of the proinflammatory immune response in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 2002;186:696-700.

26. Gerber S, Bongiovanni AM, Ledger WJ, Witkin SS. A deficiency in interferon-alpha production in women with vulvar vestibulitis. Am J Obstet Gynecol 2002;186:361-4.

27. Foster DC, Sazenski TM, Stodgell CJ. Impact of genetic variation in interleukin-1 receptor antagonist and melanocortin-1 receptor genes on vulvar vestibulitis syndrome. J Reprod Med 2004;49:503-9.

28. Jeremias J, Ledger WJ, Witkin SS. Interleukin 1 receptor antagonist gene polymorphism in women with vulvar vestibulitis. Am J Obstet Gynecol 2000;182:283-5.

29. Chadha S, Gianotten WL, Drogendijk AC, Weijmar Schultz WC, Blindeman LA, van der Meijden WI. Histopathologic features of vulvar vestibulitis. Int J Gynecol Pathol 1998;17:7-11.

30. Chaim W, Meriwether C, Gonik B, Qureshi F, Sobel JD. Vulvar vestibulitis subjects undergoing surgical intervention: a descriptive analysis and histopathological correlates. Eur J Obstet Gynecol Reprod Biol 1996;68:165-8.

31. Bornstein J, Goldschmid N, Sabo E. Hyperinnervation and mast cell activation may be used as histopathologic diagnostic criteria for vulvar vestibulitis. Gynecol Obstet Invest 2004;58:171-8.

32. Lundqvist EN, Hofer PA, Olofsson JI, Sjoberg I. Is vulvar vestibulitis an inflammatory condition? A comparison of histological findings in affected and healthy women. Acta Derm Venereol 1997;77:319-22.

33. Slone S, Reynolds L, Gall S, Peiper S, Marin A, Ackerman D, et al. Localization of chromogranin, synaptophysin, serotonin, and CXCR2 in neuroendocrine cells of the minor vestibular glands: an immunohistochemical study. Int J Gynecol Pathol 1999;18:360-5.

34. Westrom LV, Willen R. Vestibular nerve fiber proliferation in vulvar vestibulitis syndrome. Obstet Gynecol 1998;91:572-6.

35. Bohm-Starke N, Hilliges M, Falconer C, Rylander E. Increased intraepithelial innervation in women with vulvar vestibulitis syndrome. Gynecol Obstet Invest 1998;46:256-60.

36. Tympanidis P, Terenghi G, Dowd P. Increased innervation of the vulval vestibule in patients with vulvodynia. Br J Dermatol 2003;148:1021-7.

37. Reed BD. Vulvodynia. Female Patient 2005;30:48-54.

38. Pagano R. Vulvar vestibulitis syndrome: an often unrecognized cause of dyspareunia. Aust N Z J Obstet Gynaecol 1999;39:79-83.

39. Nyirjesy P, Halpern M. Medical management of vulvar vestibulitis: results of a sequential treatment plan. Infect Dis Obstet Gynecol 1996; 3:193-7.

40. Solomons CC, Melmed MH, Heitler SM. Calcium citrate for vulvar vestibulitis. A case report. J Reprod Med 1991;36:879-82.

41. Baggish MS, Sze EH, Johnson R. Urinary oxalate excretion and its role in vulvar pain syndrome. Am J Obstet Gynecol 1997;177:507-11.

42. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-6.

43. Ben-David B, Friedman M. Gabapentin therapy for vulvodynia. Anesth Analg 1999;89:1459-60.

44. Massey LK, Roman-Smith H, Sutton RA. Effect of dietary oxalate and calcium on urinary oxalate and risk of formation of calcium oxalate kidney stones. J Am Diet Assoc 1993;93:901-6.

45. Baggish MS, Miklos JR. Vulvar pain syndrome: a review. Obstet Gynecol Surv 1995;50:618-27.

46. Mann MS, Kaufman RH, Brown D Jr, Adam E. Vulvar vestibulitis: significant clinical variables and treatment outcome. Obstet Gynecol 1992; 79:122-5.

47. Bergeron S, Binik YM, Khalife S, Pagidas K, Glazer HI, Meana M, et al. A randomized comparison of group cognitive-behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain 2001;91:297-306.

48. Zolnoun DA, Hartmann KE, Steege JF. Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis. Obstet Gynecol 2003;102:84-7.

49. Nyirjesy P, Sobel JD, Weitz MV, Leaman DJ, Small MJ, Gelone SP. Cromolyn cream for recalcitrant idiopathic vulvar vestibulitis: results of a placebo controlled study. Sex Transm Infect 2001;77:53-7.

50. Glazer HI, Ledger WJ. Clinical management of vulvodynia. Rev Gynaecol Pract 2002;2:83-90.

51. Glazer HI, Rodke G, Swencionis C, Hertz R, Young AW. Treatment of vulvar vestibulitis syndrome with electromyographic biofeedback of pelvic floor musculature. J Reprod Med 1995;40:283-90.

52. Bergeron S, Brown C, Lord MJ, Oala M, Binik YM, Khalife S. Physical therapy for vulvar vestibulitis syndrome: a retrospective study. J Sex Marital Ther 2002;28:183-92.

53. Weijmar Schultz WC, van de Wiel HB. Vulvar vestibulitis syndrome: care made to measure. J Psychosom Obstet Gynaecol 2002;23:5-6.

54. Edwards L. New concepts in vulvodynia. Am J Obstet Gynecol 2003; 189(3 suppl):S24-30.

55. Bornstein J, Livnat G, Stolar Z, Abramovici H. Pure versus complicated vulvar vestibulitis: a randomized trial of fluconazole treatment. Gynecol Obstet Invest 2000;50:194-7.

56. Haefner HK, Collins ME, Davis GD, Edwards L, Foster DC, Hartmann ED, et al. The vulvodynia guideline. J Low Genit Tract Dis 2005;9:40-51.

57. O'Hare PM, Sherertz EF. Vulvodynia: a dermatologist's perspective with emphasis on an irritant contact dermatitis component. J Womens Health Gend Based Med 2000;9:565-9.

58. Segal D, Tifheret H, Lazer S. Submucous infiltration of betamethasone and lidocaine in the treatment of vulvar vestibulitis. Eur J Obstet Gynecol Reprod Biol 2003;107:105-6.

59. Marinoff SC, Turner ML, Hirsch RP, Richard G. Intralesional alpha interferon. Cost-effective therapy for vulvar vestibulitis syndrome. J Reprod Med 1993;38:19-24.

60. Bornstein J, Pascal B, Abramovici H. Intramuscular beta-interferon treatment for severe vulvar vestibulitis. J Reprod Med 1993;38:117-20.

61. Lavy Y, Lev-Sagie A, Hamani Y, Zacut D, Ben-Chetrit A. Modified vulvar vestibulectomy: simple and effective surgery for the treatment of vulvar vestibulitis. Eur J Obstet Gynecol Reprod Biol 2005;120:91-5.

62. McCormack WM, Spence MR. Evaluation of the surgical treatment of vulvar vestibulitis. Eur J Obstet Gynecol Reprod Biol 1999;86:135-8.

63. Kandyba K, Binik YM. Hypnotherapy as a treatment for vulvar vestibulitis syndrome: a case report. J Sex Marital Ther 2003;29:237-42.

64. Sand Petersen C, Weismann K. Isoprenosine improves symptoms in young females with chronic vulvodynia. Acta Derm Venereol 1996;76:404.

65. Danielsson I, Sjoberg I, Ostman C. Acupuncture for the treatment of vulvar vestibulitis: a pilot study. Acta Obstet Gynecol Scand 2001; 80:437-41.
66. Powell J, Wojnarowska F. Acupuncture for vulvodynia. J R Soc Med 1999;92:579-81.